Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT05305573
What this trial is testing

Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 26
Testing effectiveness (Phase 2)Study completedNCT02728869
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants

Who this might be right for
Rotavirus Gastroenteritis
MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. 100
Post-approval studies (Phase 4)Study completedNCT02991495
What this trial is testing

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)

Who this might be right for
Yellow Fever
Epicentre 1,630
Early research (Phase 1)Active Not RecruitingNCT07078695
What this trial is testing

A Trial of SHR-1139 in Healthy Volunteers

Who this might be right for
Psoriasis
Atridia Pty Ltd. 24
Large-scale testing (Phase 3)Study completedNCT04618939
What this trial is testing

To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children

Who this might be right for
DiphtheriaTetanus
Boryung Biopharma Co., Ltd. 218
Testing effectiveness (Phase 2)Looking for participantsNCT07600983
What this trial is testing

Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)

Who this might be right for
Streptococcus Pneumoniae Infection
CanSino Biologics Inc. 854
Testing effectiveness (Phase 2)Study completedNCT01527383
What this trial is testing

Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 354
Testing effectiveness (Phase 2)Ended earlyNCT02978222
What this trial is testing

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

Who this might be right for
Platinum Sensitive Ovarian CancerOvarian Cancer
Marker Therapeutics, Inc. 120
Large-scale testing (Phase 3)Ended earlyNCT01160237
What this trial is testing

Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM

Who this might be right for
Influenza
GlaxoSmithKline 7
Early research (Phase 1)Study completedNCT02589795
What this trial is testing

Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers

Who this might be right for
HIV
Imperial College London 28
Large-scale testing (Phase 3)Study completedNCT00289172
What this trial is testing

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 360
Early research (Phase 1)Study completedNCT04826094
What this trial is testing

Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 143
Early research (Phase 1)Not Yet RecruitingNCT06986239
What this trial is testing

Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant

Who this might be right for
Vaccine Reaction
LiteVax BV 80
Large-scale testing (Phase 3)WithdrawnNCT06567457
What this trial is testing

Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty
Large-scale testing (Phase 3)Study completedNCT02640612
What this trial is testing

Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Boehringer Ingelheim 430
Post-approval studies (Phase 4)Not Yet RecruitingNCT07621341
What this trial is testing

Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old

Who this might be right for
PertussisDiphtheriaTetanus+1 more
Chiang Mai University 320
Large-scale testing (Phase 3)UnknownNCT06068556
What this trial is testing

Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition)

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Testing effectiveness (Phase 2)Study completedNCT04789577
What this trial is testing

Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

Who this might be right for
Influenza, Human
GlaxoSmithKline 833
Early research (Phase 1)Study completedNCT06095427
What this trial is testing

A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection

Who this might be right for
Healthy
Luye Pharma Group Ltd. 300
Next Page